Dawn Graham

Companies

• ACELYRIN, Inc.Board member May 4, 2023 to now¹
• Avalanche BiotechnologiesBoard member Dec 11, 2020 to now²
• Xenon PharmaceuticalsBoard member Sep 27, 2016 to now³
• Global Blood Therapeutics, Inc.Board member Dec 21, 2018 to Oct 6, 2022⁴
• PTC TherapeuticsBoard member Jun 13, 2016 to Jun 10, 2022⁵
• MedivationBoard member Apr 23, 2013 to Sep 30, 2016⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PTC Therapeutics PTCT29,017 shares⁷$1.8M at $60.99Jun 9, 2022
• XPXenon Pharmaceuticals XENE31,373 shares⁸$1.1M at $34.78Sep 1, 2026
• ABAvalanche Biotechnologies ADVM0 shares⁹Dec 9, 2025
• GBGlobal Blood Therapeutics, Inc.0 shares¹⁰Oct 5, 2022
• AACELYRIN, Inc.0 shares¹¹May 21, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 1, 2026Exercised options 5,144 shares at $8.15 of Xenon Pharmaceuticals⁸
• Jun 1, 2026Shares withheld for tax 1,416 shares at $53.41 of Xenon Pharmaceuticals¹²
• Jun 1, 2026Exercised options 2,645 shares of Xenon Pharmaceuticals¹²
• Dec 9, 2025U 5,000 shares of Avalanche Biotechnologies⁹
• May 21, 2025Returned to company 15,000 shares of ACELYRIN, Inc.¹¹
• Aug 24, 2023Sold 25,000 shares at $38.70 of Xenon Pharmaceuticals¹³
• May 9, 2023Bought 15,000 shares at $18.00 of ACELYRIN, Inc.¹⁴
• Oct 5, 2022Returned to company 5,376 shares of Global Blood Therapeutics, Inc.¹⁰
• Jun 21, 2022Sold 1,908 shares at $27.24 of Global Blood Therapeutics, Inc.¹⁵
• Jun 14, 2022Exercised options 3,600 shares of Global Blood Therapeutics, Inc.¹⁶
• Jun 9, 2022Sold 738 shares at $27.20 of PTC Therapeutics⁷
• May 16, 2022Bought 30,000 shares at $0.85 of Avalanche Biotechnologies¹⁷
• Jan 7, 2022Granted 3,200 shares of PTC Therapeutics¹⁸
• Jan 7, 2022Sold 510 shares at $38.53 of PTC Therapeutics¹⁸